METTL14 and breast carcinoma: Deregulations have also been found at the level of readers, erasers, and writers of already described chemical modifications, particularly for m6A. For instance, in breast cancer some erasers and writers seem to be related to hypoxic condition (ALKBH5), and respectively to a shorter survival of patients as a consequence of a lower expression (METTL14).